294 related articles for article (PubMed ID: 31936134)
21. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
Kurikawa N; Takagi T; Wakimoto S; Uto Y; Terashima H; Kono K; Ogata T; Ohsumi J
Biol Pharm Bull; 2013; 36(2):259-67. PubMed ID: 23370355
[TBL] [Abstract][Full Text] [Related]
22. Hepatic Stearoyl-CoA desaturase-1 deficiency-mediated activation of mTORC1- PGC-1α axis regulates ER stress during high-carbohydrate feeding.
Aljohani A; Khan MI; Syed DN; Abram B; Lewis S; Neill LO; Mukhtar H; Ntambi JM
Sci Rep; 2019 Oct; 9(1):15761. PubMed ID: 31673045
[TBL] [Abstract][Full Text] [Related]
23. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
[TBL] [Abstract][Full Text] [Related]
25. SCD1 mediates the influence of exogenous saturated and monounsaturated fatty acids in adipocytes: Effects on cellular stress, inflammatory markers and fatty acid elongation.
Ralston JC; Metherel AH; Stark KD; Mutch DM
J Nutr Biochem; 2016 Jan; 27():241-8. PubMed ID: 26481476
[TBL] [Abstract][Full Text] [Related]
26. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
27. Role of Stearoyl-CoA Desaturase 1 in Cardiovascular Physiology.
Balatskyi VV; Dobrzyn P
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982607
[TBL] [Abstract][Full Text] [Related]
28. Insights into Stearoyl-CoA Desaturase-1 Regulation of Systemic Metabolism.
ALJohani AM; Syed DN; Ntambi JM
Trends Endocrinol Metab; 2017 Dec; 28(12):831-842. PubMed ID: 29089222
[TBL] [Abstract][Full Text] [Related]
29. Regulation of stearoyl-CoA desaturases and role in metabolism.
Ntambi JM; Miyazaki M
Prog Lipid Res; 2004 Mar; 43(2):91-104. PubMed ID: 14654089
[TBL] [Abstract][Full Text] [Related]
30. Loss of Stearoyl-CoA Desaturase-1 Activity Induced Leptin Resistance in Neuronal Cells.
Thon M; Hosoi T; Chea C; Ozawa K
Biol Pharm Bull; 2017; 40(8):1161-1164. PubMed ID: 28768997
[TBL] [Abstract][Full Text] [Related]
31. PDGF-induced fibroblast growth requires monounsaturated fatty acid production by stearoyl-CoA desaturase.
Coomans de Brachène A; Dif N; de Rocca Serra A; Bonnineau C; Velghe AI; Larondelle Y; Tyteca D; Demoulin JB
FEBS Open Bio; 2017 Mar; 7(3):414-423. PubMed ID: 28286737
[TBL] [Abstract][Full Text] [Related]
32. Recent insights into stearoyl-CoA desaturase-1.
Ntambi JM; Miyazaki M
Curr Opin Lipidol; 2003 Jun; 14(3):255-61. PubMed ID: 12840656
[TBL] [Abstract][Full Text] [Related]
33. Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
Iida T; Ubukata M; Mitani I; Nakagawa Y; Maeda K; Imai H; Ogoshi Y; Hotta T; Sakata S; Sano R; Morinaga H; Negoro T; Oshida S; Tanaka M; Inaba T
Eur J Med Chem; 2018 Oct; 158():832-852. PubMed ID: 30248655
[TBL] [Abstract][Full Text] [Related]
34. Sterculic acid antagonizes 7-ketocholesterol-mediated inflammation and inhibits choroidal neovascularization.
Huang JD; Amaral J; Lee JW; Larrayoz IM; Rodriguez IR
Biochim Biophys Acta; 2012 Apr; 1821(4):637-46. PubMed ID: 22342272
[TBL] [Abstract][Full Text] [Related]
35. Stearoyl-CoA desaturase activity in bovine cumulus cells protects the oocyte against saturated fatty acid stress.
Aardema H; van Tol HTA; Wubbolts RW; Brouwers JFHM; Gadella BM; Roelen BAJ
Biol Reprod; 2017 May; 96(5):982-992. PubMed ID: 28486699
[TBL] [Abstract][Full Text] [Related]
36. Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins.
Rios-Esteves J; Resh MD
Cell Rep; 2013 Sep; 4(6):1072-81. PubMed ID: 24055053
[TBL] [Abstract][Full Text] [Related]
37. Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids.
Southam AD; Khanim FL; Hayden RE; Constantinou JK; Koczula KM; Michell RH; Viant MR; Drayson MT; Bunce CM
Cancer Res; 2015 Jun; 75(12):2530-40. PubMed ID: 25943877
[TBL] [Abstract][Full Text] [Related]
38. [Stearoyl-CoA desaturase in the control of metabolic homeostasis].
Dobrzyń P
Postepy Biochem; 2012; 58(2):166-74. PubMed ID: 23214140
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
[TBL] [Abstract][Full Text] [Related]
40. Stearoyl-CoA desaturase-1 and adaptive stress signaling.
Koeberle A; Löser K; Thürmer M
Biochim Biophys Acta; 2016 Nov; 1861(11):1719-1726. PubMed ID: 27550503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
